VOPROSY MEDITSINSKOI KHIMII (ISSN 0042-8809)

Improvement of the diabetic neuropathy by picamilon and aldosereductase inhibitors

   
Kuchmerovskaya T.M., Parchometc P.K., Donchenko G.V., Obrosova Y.G., Klimenko A.P., Kuchmerovsky N.A., Pakyrbayeva L.V., Efimov A.S.
PubMed Id: 10599142
Year: 1998  Volume: 44  Issue: 6  Pages: 559-564
Streptosotocin-induced diabetes in rats is accompanied by the development of diabetic complications such as neuropathies. [2-14C]serotonin and [U-14C]GABA release from the neurotransmitter pre-loaded synaptosomes showed significant elevation. Aldose reductase inhibitors (AL-1576, sorbinil) administration leads to partial restoration of serotonin and GABA release, while picamilon restored only GABA release. It was shown that Na+,K(+)-ATPase activities decreased in synaptosomes, synaptic membranes and sciatic nerve of diabetic rats compared to control. Administration of AL-1576 normalized Na+, K(+)-ATPase activity, while sorbinil and picamilon less effectively. Sorbitol level are increased in streptozotocin-diabetic rats as compared to control. The picamilon and aldose reductase inhibitors administration to diabetic rats is accompanied by the partial reduction of brain sorbitol level. The findings confirm the important role of picamilon and aldose reductase inhibitors in the prevention and treatment of diabetic neuropathy.
Download PDF:  
Keywords: diabetic neuropathy, aldose reductase inhibition, synaptosomes
Citation:

Kuchmerovskaya, T. M., Parchometc, P. K., Donchenko, G. V., Obrosova, Y. G., Klimenko, A. P., Kuchmerovsky, N. A., Pakyrbayeva, L. V., Efimov, A. S. (1998). Improvement of the diabetic neuropathy by picamilon and aldosereductase inhibitors. Voprosy Meditsinskoi Khimii, 44(6), 559-564.
References  
 2002 (vol 48)
 2001 (vol 47)
 2000 (vol 46)
 1999 (vol 45)
 1998 (vol 44)
 1997 (vol 43)
 1996 (vol 42)
 1995 (vol 41)
 1994 (vol 40)
 1993 (vol 39)
 1992 (vol 38)
 1991 (vol 37)
 1990 (vol 36)
 1989 (vol 35)
 1988 (vol 34)
 1987 (vol 33)
 1986 (vol 32)
 1985 (vol 31)